Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs

BACKGROUND: There is no widely accepted standard medical treatment for apocrine gland anal sac adenocarcinoma (AGASACA) in dogs. Targeted agents such as toceranib may be effective in treatment of AGASACA, but the number of clinical reports investigating its efficacy is limited. HYPOTHESIS/AIM: To ev...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Vet Intern Med
Asıl Yazarlar: Heaton, Caitlin M., Fernandes, Arthur F. A., Jark, Paulo C., Pan, Xuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
SMALL ANIMAL
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7096647/
https://ncbi.nlm.nih.gov/pubmed/31977135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15706
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller